Oct 19 (Reuters) – NextCell Pharma AB: * PROTRANS-YOUNG CLINICAL TRIAL HAVE NOT YET BEEN REPORTED TO COMPANY * EXTENDED TIMELINE IS DUE TO FINAL ADMINISTRATIVE PROCESSING AND SIGN-OFF OF STUDY DATA
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 19 (Reuters) - BROOKFIELD ASSET MANAGEMENT LTD : * TO INVEST TENS OF BILLIONS…
LONDON, Oct 19 (Reuters) - Uber on Monday said it had won its bid to…
LONDON, Oct 19 (Reuters) - Uber on Monday said it had won its bid to…
Oct 19 (Reuters) - PGE Polska Grupa Energetyczna SA : * ADOPTS UPDATED GROUP STRATEGY…
Following its IPO, ENS Enterprises is expanding its role in digital commerce, moving beyond technology…
LONDON, Oct 19 (Reuters) - Uber on Monday said it had won its bid to…